In this study, we combined scRNA-seq and Bulk RNA-Seq to investigate the ability of the CD8+ T-cell exhaustion signature to predict the prognosis and immunotherapy response in HBV-related HCC patients (Fig. 1). The gene discussed is CD8A; the disease is hepatocellular carcinoma.